SAMSON MARVIN 4
4 · ANTARES PHARMA, INC. · Filed Jan 14, 2020
Insider Transaction Report
Form 4
SAMSON MARVIN
Director
Transactions
- Exercise/Conversion
Common Stock
2020-01-10$2.66/sh+56$149→ 51,807 total - Sale
Common Stock
2020-01-10$4.50/sh−56$252→ 51,751 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-10−56→ 0 totalExercise: $2.66From: 2018-06-07Exp: 2027-06-06→ Common Stock (56 underlying)
Footnotes (2)
- [F1]The stock option exercise and sale of common stock reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan established in connection with estate planning and represents the remaining balance of a previously unexercised option grant to be transacted under the plan.
- [F2]The options vested and became exercisable in four quarterly installments over the one-year period following the grant date of June 7, 2017.